▽Pharmaceutical Business Review - Industry News, Information, Research ●11/22 16:40 Metabolic DisordersNovember 21, 2024Laekna partners with Lilly to develop obesity therapyLaekna has entered into a clinical partnership with Eli Lilly to advance the development of LAE102, a new ActRIIA monoclonal antibody for treating obesity.ContinueDrug ManufacturingNeurologyNumab Therapeutics and Kaken Pharmaceutical collaborate to develop ND081Oncology